# LYRFIGTU
> **NDA220425** · New Drug Application · Sponsor: ELEVAR THERAPEUTICS INC · Approved 2026-09-23
## Drug
- **FDA Application Number:** NDA220425
- **Application type:** New Drug Application
- **Brand name:** LYRFIGTU
- **Generic name:** Lirafugratinib Hydrochloride
- **Active ingredients:** LIRAFUGRATINIB HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ELEVAR THERAPEUTICS INC
- **First approval:** 2026-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220425)
---
*MORVS · CC0 1.0*